Research Priorities
Are Canadians kept in the dark about potential drug safety risks?
By dcc2012 | April 29, 2019
Government warnings about potential drug safety risks vary significantly across countries, according to a new study co-authored by UBC researchers.
Most British Columbians support policies to boost vaccine uptake: New research
By Reyhana Heatherington | April 24, 2019
According to the study, more than 80 per cent of respondents held positive attitudes towards immunization.
UBC’s Kim McGrail is leading an $81M initiative to increase access to health research data
By dcc2012 | April 23, 2019
The new platform will make it easier for researchers to access and analyze health research data.
Global leader in precision cancer drug design joins the faculty of medicine
By Reyhana Heatherington | April 17, 2019
Dr. Sriram Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy.
Putting Canada at the forefront of precision medicine
By dcc2012 | April 17, 2019
Sriram Subramaniam joins UBC as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.
UBC attracts over $40M to host Networks of Centres of Excellence in nanomedicines
By dcc2012 | April 16, 2019
Led by Pieter Cullis, the NanoMedicines Innovation Network aims to develop nanomedicines that will deliver drugs more specifically to the sites of disease.
New study first to identify an expanded section of DNA as cause of a rare genetic metabolic disorder
By dcc2012 | April 15, 2019
Researchers found an unusual genetic mutation behind three children’s undiagnosed, degenerative conditions.
Filtered diesel exhaust may worsen allergy-induced lung impairment more than unfiltered
By dcc2012 | April 12, 2019
Filtered air pollution from diesel engines could make allergy-induced lung impairment worse than exposure to unfiltered diesel exhaust.
First-of-its-kind imaging facility to accelerate brain research at UBC
By dcc2012 | April 9, 2019
The Charles E. Fipke Integrated Neuroimaging Suite is unique, with its PET-MRI machine dedicated solely to brain-related research.
Psychedelics: A new frontier in addiction medicine
By Reyhana Heatherington | April 8, 2019
The philanthropic community steps up to fill a funding gap in psychedelic-assisted therapy for treating opioid and other substance use disorders.